DVCD AL denied as not FDA-approved for this use by Blue Cross Blue Shield?
Off-label use is widespread in medicine. If the literature and a recognised specialty-society guideline support the use, plans frequently approve on appeal — especially for cancer, cardiology, and rare disease.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Blue Cross Blue Shield typically requires
Blue Cross Blue Shield's specific coverage criteria for dvcd al are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Blue Cross Blue Shield angle on DVCD AL
## Why BCBS May Deny a Medical Device for Alcohol Use Disorder as "Not FDA-Approved"
Blue Cross Blue Shield plans routinely screen device claims against FDA clearance or approval status. If your claim was denied as "not FDA-approved," the plan is asserting that the specific device — or its intended use — lacks the required FDA marketing authorization. This denial is frequently issued in error when a device carries 510(k) clearance (which is a form of FDA authorization) rather than a Premarket Approval (PMA), or when the billing code does not precisely match the FDA-cleared indication on file.
## Why This Denial Is Appealable
FDA 510(k) clearance is legal marketing authorization under federal law. A plan that conflates "not PMA-approved" with "not FDA-approved" is applying an incorrect standard. Additionally, if the device is prescribed for its FDA-cleared indication, the "not approved" rationale collapses. BCBS's own medical policy must define exactly what authorization level it requires; if the policy language is ambiguous, that ambiguity is resolved in the enrollee's favor under ERISA.
## Federal Appeal Framework
- Internal appeal: Under ACA §2719 and ERISA §503, you have the right to a full-and-fair internal review. File within the deadline shown on your denial letter (typically 180 days for ERISA plans).
- External review: After exhausting internal appeals — or if BCBS does not decide within the regulatory timeframe — you may request an Independent Review Organization (IRO) review. The external-review window is generally within four months of the final internal denial. Expedited external review is available when a standard timeline would seriously jeopardize your health.
## Concrete Appeal Steps
1. Obtain the denial letter and identify the exact policy or LCD/NCD language cited. 2. Pull the device's FDA 510(k) clearance letter (available free at fda.gov/medical-devices) and confirm the cleared indication matches your prescribed use. 3. Ask your prescriber to write a medical-necessity letter explicitly mapping the prescribed use to the FDA-cleared indication. 4. Request BCBS's current medical policy for this device category in writing. 5. Submit internal appeal with the FDA clearance document, prescriber letter, and a point-by-point rebuttal of the denial rationale.
## Documentation to Gather
- Diagnosis confirmation: Chart notes and ICD-10 codes establishing alcohol use disorder and severity.
- Prior-treatment history: Dated records of behavioral interventions, medications, or prior devices tried, with outcomes noted.
- Clinical severity: Screening scores, clinician assessment of relapse risk, and any documented health consequences of continued alcohol use (from your chart — no numbers need be fabricated; use your actual documented values).
- Prescriber letter: A letter from the ordering clinician explaining why this device is medically necessary for your specific case and confirming the prescribed use matches the FDA-cleared indication.
- FDA clearance document: Printed or PDF copy of the 510(k) clearance summary.
## Criteria-Mapping Structure
Create a two-column table. In the left column, copy each requirement from BCBS's published medical policy for this device (request it if you do not have it). In the right column, cite the exact chart note, date, and clinician statement that satisfies each requirement. Do the same for the FDA-cleared indication versus the prescribed use. A well-matched table is the single most persuasive element of a device appeal.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →Related appeal guides
- Blue Cross Blue Shield denied as not FDA-approved for this use of 17ohp Compounded
- Blue Cross Blue Shield denied as not FDA-approved for this use of AAT Augmentation
- Blue Cross Blue Shield denied as not FDA-approved for this use of Amphetamine Stimulant Prodrug
- Blue Cross Blue Shield denied as not FDA-approved for this use of Anti Cd 20 Ocrevus